Foresee Pharmaceuticals, Inc. Delivers
Comfort, Compliance, Convenience and Cure To Better A Patient's Life

Home | Sitemap | Contact
Links to Navigate



dotted line

strelka 2 Home

dotted line

strelka 2 About Us

dotted line

strelka 2 Technology

dottend line

strelka 2 Product Pipeline

dotted line

strelka 2 Partnerships

dotted line

strelka 2 News

dotted line

strelka 2 Contact Us

dotted line

about us

About Foresee Pharmaceuticals, Inc.

Products We are Working On

FP-001-
Prostate Cancer

FP-025-
Asthma and COPD

FP-002-
Acromegaly

FP-004- Opioid Dependance

FP-005-
Diabetes

Read more about Foresee's Products

news

Foresee's News

October, 2014 - Foresee Pharmaceuticals, Inc., closed $18 million of series C funding.

August, 2014 - Foresee Pharmaceuticals, Inc. announced its FP-001 pipeline candidate entering into global phase 3 registration trial (ClinicalTrials.gov Identifier: NCT02234115).

dadsfasddfRead more about Foresee's Products

Foresee Pharmaceuticals, Inc. Delivers Comfort, Compliance, Convenience and Cure To Better A Patient's Life.ee Pharmacdsafseuticals, LLC. (FP) is an emempany built aroua controlled-relpharmaceuticalpdfdsafsdfdsdfdsafsdfdl

Drug Delivery Technologies

SIF Pic


Our Partnerships

On January 30th, 2013, Foresee Pharmaceuticals, Inc. entered into a joint venture agreement with ScinoPharm Taiwan, Ltd., a public traded Traiwan based leading process R&D and API manufacturing service provider to the global pharmaceutical industry.


About Us | Technology | Product Pipeline | Partnerships | News
dsdfasdfasfasdfasdfasdfddasfd 3 Innovation Way Suite 240, Newark, Delaware,; 19711 USA
Home | Sitemap | Contact copyright (c) 2013. Foresee Pharmaceuticals, Inc.. All right reserved. Privacy policy | User Agreement
Read more about Foresee Pharmaceuticals Read more about Foresee's Technology Read more about investing in Foresee